Paraskevi Kallinteri

1.4k total citations
19 papers, 1.1k citations indexed

About

Paraskevi Kallinteri is a scholar working on Molecular Biology, Biomaterials and Materials Chemistry. According to data from OpenAlex, Paraskevi Kallinteri has authored 19 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Biomaterials and 5 papers in Materials Chemistry. Recurrent topics in Paraskevi Kallinteri's work include Nanoparticle-Based Drug Delivery (10 papers), RNA Interference and Gene Delivery (5 papers) and Advanced Drug Delivery Systems (4 papers). Paraskevi Kallinteri is often cited by papers focused on Nanoparticle-Based Drug Delivery (10 papers), RNA Interference and Gene Delivery (5 papers) and Advanced Drug Delivery Systems (4 papers). Paraskevi Kallinteri collaborates with scholars based in United Kingdom, Greece and United States. Paraskevi Kallinteri's co-authors include Martin C. Garnett, Sophia G. Antimisiaris, Gillian A. Hutcheon, S. J. Higgins, Dimitrios G. Fatouros, Vivek Dhawan, Mohammed Elmowafy, Tomasz Róg, Tapani Viitala and Aniket Magarkar and has published in prestigious journals such as Biomaterials, Scientific Reports and The Journal of Physical Chemistry C.

In The Last Decade

Paraskevi Kallinteri

19 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paraskevi Kallinteri United Kingdom 14 462 404 251 226 205 19 1.1k
Suneel Pandey India 6 422 0.9× 303 0.8× 166 0.7× 305 1.3× 307 1.5× 10 1.1k
Marie Gaumet Switzerland 6 495 1.1× 267 0.7× 178 0.7× 292 1.3× 313 1.5× 7 1.0k
Claire Gueutin France 23 360 0.8× 329 0.8× 209 0.8× 217 1.0× 339 1.7× 44 1.2k
Otilia Koo United States 11 403 0.9× 254 0.6× 184 0.7× 260 1.2× 208 1.0× 16 882
Gabriela Calderó Spain 16 403 0.9× 218 0.5× 198 0.8× 217 1.0× 203 1.0× 36 956
Ye Jiang China 15 499 1.1× 361 0.9× 194 0.8× 354 1.6× 115 0.6× 31 1.2k
Moo J. Cho United States 11 438 0.9× 460 1.1× 121 0.5× 262 1.2× 151 0.7× 21 1.0k
Gaëlle Roullin Canada 20 472 1.0× 219 0.5× 303 1.2× 316 1.4× 185 0.9× 51 1.2k
Wenzhi Yang China 20 434 0.9× 245 0.6× 139 0.6× 254 1.1× 220 1.1× 42 1.2k
Tiago dos Santos Portugal 13 408 0.9× 385 1.0× 339 1.4× 279 1.2× 141 0.7× 28 1.2k

Countries citing papers authored by Paraskevi Kallinteri

Since Specialization
Citations

This map shows the geographic impact of Paraskevi Kallinteri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paraskevi Kallinteri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paraskevi Kallinteri more than expected).

Fields of papers citing papers by Paraskevi Kallinteri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paraskevi Kallinteri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paraskevi Kallinteri. The network helps show where Paraskevi Kallinteri may publish in the future.

Co-authorship network of co-authors of Paraskevi Kallinteri

This figure shows the co-authorship network connecting the top 25 collaborators of Paraskevi Kallinteri. A scholar is included among the top collaborators of Paraskevi Kallinteri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paraskevi Kallinteri. Paraskevi Kallinteri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Magarkar, Aniket, Vivek Dhawan, Paraskevi Kallinteri, et al.. (2014). Cholesterol level affects surface charge of lipid membranes in saline solution. Scientific Reports. 4(1). 5005–5005. 174 indexed citations
2.
Favretto, Marco E., Panayiotis V. Ioannou, Ignacio A. Romero, et al.. (2014). Permeability of PEGylated Immunoarsonoliposomes Through In Vitro Blood Brain Barrier-Medulloblastoma Co-culture Models for Brain Tumor Therapy. Pharmaceutical Research. 32(3). 1072–1083. 17 indexed citations
3.
Bouropoulos, Nikolaos, Orestis L. Katsamenis, Paul A. Cox, et al.. (2012). Probing the Perturbation of Lecithin Bilayers by Unmodified C60 Fullerenes Using Experimental Methods and Computational Simulations. The Journal of Physical Chemistry C. 116(6). 3867–3874. 8 indexed citations
4.
Wahab, Abdul, et al.. (2012). Development of poly(glycerol adipate) nanoparticles loaded with non-steroidal anti-inflammatory drugs. Journal of Microencapsulation. 29(5). 497–504. 13 indexed citations
5.
Favretto, Marco E., et al.. (2009). Arsonoliposomes for the Potential Treatment of Medulloblastoma. Pharmaceutical Research. 26(10). 2237–2246. 5 indexed citations
6.
Slipper, Ian J., et al.. (2009). Inclusion of poorly soluble drugs in highly ordered mesoporous silica nanoparticles. International Journal of Pharmaceutics. 387(1-2). 272–277. 107 indexed citations
7.
Bakandritsos, Aristides, Radek Zbořil, Nikolaos Bouropoulos, et al.. (2009). The preparation of magnetically guided lipid based nanoemulsions using self-emulsifying technology. Nanotechnology. 21(5). 55104–55104. 4 indexed citations
8.
Orafai, Hossein M., et al.. (2008). Novel Poly (glycerol-adipate) Polymers Used for Nanoparticle Making: A Study of Surface Free Energy. Iranian journal of pharmaceutical research. 7(1). 11–19. 13 indexed citations
9.
Kallinteri, Paraskevi, et al.. (2007). Drug incorporation and release of water soluble drugs from novel functionalised poly(glycerol adipate) nanoparticles. Journal of Controlled Release. 125(1). 59–67. 61 indexed citations
10.
Meng, Wei, Paraskevi Kallinteri, David Walker, Terry Parker, & Martin C. Garnett. (2007). Evaluation of Poly (Glycerol-Adipate) Nanoparticle Uptake in an In Vitro 3-D Brain Tumor Co-Culture Model. Experimental Biology and Medicine. 232(8). 1100–1108. 31 indexed citations
11.
Garnett, Martin C. & Paraskevi Kallinteri. (2006). Nanomedicines and nanotoxicology: some physiological principles. Occupational Medicine. 56(5). 307–311. 253 indexed citations
12.
Meng, Wei, Terry Parker, Paraskevi Kallinteri, et al.. (2006). Uptake and metabolism of novel biodegradable poly (glycerol-adipate) nanoparticles in DAOY monolayer. Journal of Controlled Release. 116(3). 314–321. 43 indexed citations
13.
Kallinteri, Paraskevi, et al.. (2005). Novel Functionalized Biodegradable Polymers for Nanoparticle Drug Delivery Systems. Biomacromolecules. 6(4). 1885–1894. 122 indexed citations
14.
Kallinteri, Paraskevi, Dimitrios G. Fatouros, Pavlos Klepetsanis, & Sophia G. Antimisiaris. (2004). Arsenic Trioxide Liposomes: Encapsulation Efficiency and In Vitro Stability. Journal of Liposome Research. 14(1-2). 27–38. 35 indexed citations
16.
Kallinteri, Paraskevi, et al.. (2001). Characterization, Stability and In - Vivo Distribution of Asialofetuin Glycopeptide Incorporating DSPC/CHOL Liposomes Prepared by Mild Cholate Incubation. Journal of drug targeting. 9(2). 155–168. 5 indexed citations
17.
Kallinteri, Paraskevi & Sophia G. Antimisiaris. (2001). Solubility of drugs in the presence of gelatin: effect of drug lipophilicity and degree of ionization. International Journal of Pharmaceutics. 221(1-2). 219–226. 28 indexed citations
18.
Kallinteri, Paraskevi, Εvangelia Papadimitriou, & Sophia G. Antimisiaris. (2001). UPTAKE OF LIPOSOMES WHICH INCORPORATE A GLYCOPEPTIDE FRACTION OF ASIALOFETUIN BY HepG2CELLS. Journal of Liposome Research. 11(2-3). 175–193. 4 indexed citations
19.
Kallinteri, Paraskevi, et al.. (2000). Stability of SUV liposomes in the presence of cholate salts and pancreatic lipases: effect of lipid composition. European Journal of Pharmaceutical Sciences. 9(3). 245–252. 114 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026